FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to otorhinolaryngology, and concerns treating neurosensory hearing loss. Method involves administration of etiotropic and symptomatic therapy in accordance with international and national recommendations, in combination with the Semax drug preparation in the form of nasal drops, which is introduced into each half of the patient's nose cavity in dose of 1–1.5 mg 3 times a day for three days, then 0.5–1 mg for two weeks and then 150–300 mcg for two weeks.
EFFECT: invention provides reducing a threshold of auditory perception of the patient, improving speech intelligibility and reducing the probability of undesired reactions.
1 cl, 3 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING ACUTE AND SUDDEN SENSORINEURAL HEARING LOSS AND DEAFNESS | 2014 |
|
RU2563829C1 |
| METHOD FOR THE TREATMENT OF ACUTE ACOUSTIC INJURY | 2022 |
|
RU2783255C1 |
| METHOD FOR TREATING NEUROSENSORY HYPOACUSIA | 2001 |
|
RU2188642C1 |
| METHOD FOR EVALUATING RESTORED AUDITORY FUNCTION IN ACUTE PERIOD OF SENSONEURAL IMPAIRED HEARING | 2002 |
|
RU2224256C2 |
| METHOD FOR TREATING PATIENTS FOR POSTTRAUMATIC SENSORINEURAL DEAFNESS IN ACUTE STAGE CAUSED BY MINE EXPLOSION INJURY | 2006 |
|
RU2323019C1 |
| METHOD FOR TREATING SENSONEURAL IMPAIRED HEARING | 2003 |
|
RU2232014C1 |
| METHOD FOR SURGICAL TREATMENT OF CHRONIC SECONDARY SENSONEURAL DEAFNESS | 2016 |
|
RU2651110C1 |
| METHOD FOR TREATING THE CASES OF NEUROSENSORY HYPACUSIA | 1998 |
|
RU2143876C1 |
| METHOD FOR TREATING ACQUIRED NEUROSENSORY IMPAIRED HEARING | 2001 |
|
RU2243773C2 |
| METHOD FOR TREATING NEURITIS OF AUDITORY NERVE | 2001 |
|
RU2195272C1 |
